Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ATG-Fresenius
Gräfelfing, Bavaria, Germany
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Neovii Biotech is a global biopharmaceutical company specializing in the development and commercialization of novel life-transforming therapies in the fields of transplantation medicine, hemato-oncology, and immune disorders. The company is best known for its flagship product Grafalon (formerly known as ATG-Fresenius), a rabbit anti-human T-lymphocyte globulin used to prevent and treat organ transplant rejection and graft-versus-host disease. Originally a subsidiary of Fresenius SE under the name Fresenius Biotech, the company was acquired by the Neopharm Group in 2013 and rebranded as Neovii. Neovii maintains a strong focus on polyclonal antibody technology and continues to manufacture its core products in specialized facilities in Germany.
- Therapeutic areas
- HematologyImmunology
- Modalities
- AntibodyPolyclonal antibodyBiologic
- Industry
- Biotech
02
Partnerships
Fresenius SE
Beyond the preview
Go deeper on ATG-Fresenius.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATG-Fresenius.